0.5 %The prevalence of HCV infection was 0.5% among HIV-naïve children in Lagos.
Nigeriahépatite C · VIH/sidapublished 2020PloS onePubMeddocument of 4 observations
Gold tier: mechanically validated evidence, with its primary source.
66 evidence items · page 2 / 3
0.5 %The prevalence of HCV infection was 0.5% among HIV-naïve children in Lagos.
Nigeriahépatite C · VIH/sidapublished 2020PloS onePubMeddocument of 4 observations
0.8 %Hepatitis C seropositivity was observed in 10 (0.8%) of 1329 patients enrolled for haemodialysis between 2019 and 2022 in four public dialysis centres in Kano and Jigawa state, Northwest Nigeria.
Nigeriahépatite Cobserved 2019–2022published 2023The Nigerian postgraduate medical journalPubMeddocument of 10 observations
0.14 %Among 2775 pregnant women in Nigeria, the seroprevalence of triplex infection with HIV, HBV, and HCV was 0.14%.
Nigeriahépatite B · hépatite C · VIH/sidapublished 2025Antiviral therapyPubMeddocument of 7 observations
100 US$Commodity costs for hepatitis C virus diagnostics fell from over US$100 per diagnostic test.
Nigeriahépatite Cpublished 2020BMJ global healthPubMeddocument of 6 observations
1.3 %Hepatitis C virus seroprevalence among pregnant women in Nigeria was 1.3%.
Nigeriahépatite Cpublished 2021Women's health (London, England)PubMeddocument of 7 observations
14.6 %The prevalence of Hepatitis C co-infection among people living with HIV/AIDS in a rural Northern Nigerian community was 14.6%.
Nigeriahépatite C · VIH/sidapublished 2020The Pan African medical journalPubMeddocument of 4 observations
2.6 %The prevalence of hepatitis C virus (HCV) among patients attending public hospitals in Lagos, Nigeria was 2.6%.
Nigeriahépatite Cpublished 2025The Nigerian postgraduate medical journalPubMeddocument of 7 observations
0.47 %Among 2775 pregnant women in Nigeria, the seroprevalence of dual infection with HIV, HBV, and HCV was 0.47%.
Nigeriahépatite B · hépatite C · VIH/sidapublished 2025Antiviral therapyPubMeddocument of 7 observations
2,300,000 peopleGlobally, approximately 2.3 million people living with HIV are co-infected with hepatitis C virus.
Nigeriahépatite C · VIH/sidapublished 2024Journal of infection in developing countriesPubMeddocument of 5 observations
0.64 %The prevalence of HIV/HBV/HCV triple co-infection among HIV-positive patients attending three major hospitals in the Federal Capital Territory, Nigeria was 0.64%.
Nigeriahépatite B · hépatite C · VIH/sidaobserved 2019published 2020Journal of immunoassay & immunochemistryPubMeddocument of 9 observations
0 %The mother-to-child transmission (MTCT) rate for HIV, HBV, and HCV among pregnant women in Nigeria was 0% at 6-week post-delivery.
Nigeriahépatite B · hépatite C · VIH/sidaobserved 6-week post-deliverypublished 2025Antiviral therapyPubMeddocument of 7 observations
0.6 %Dual seropositivity of anti-hepatitis C virus/anti-HIV among pregnant women in Nigeria accounted for 0.6%.
Nigeriahépatite C · VIH/sidapublished 2021Women's health (London, England)PubMeddocument of 7 observations
4.8 %Hepatitis C virus (HCV) prevalence was 4.8% among 248 patients at the Federal Medical Center, Makurdi.
Nigeriahépatite Cpublished 2024BMC public healthPubMeddocument of 7 observations
0.5 %The prevalence of HCV infection was 0.5% among HIV-infected children in Lagos.
Nigeriahépatite C · VIH/sidapublished 2020PloS onePubMeddocument of 4 observations
0 casesNone of the 204 HIV-infected children and young adults tested in Calabar, Nigeria were positive for HCV antibody.
Nigeriahépatite Cpublished 2024Journal of infection in developing countriesPubMeddocument of 5 observations
0.3 %The hepatitis C prevalence in non-conflict zones in Nigeria was 0.3%.
Nigeriahépatite Cobserved 2018published 2021Annals of global healthPubMeddocument of 12 observations
4.1 %Among all donors tested for transfusion transmissible infections, 358 (4.1%) tested positive for Hepatitis C.
Nigeriahépatite Cobserved 2020-2022published 2025BMC infectious diseasesPubMeddocument of 17 observations
0.218 pearson_correlation_coefficientA positive correlation was found between age and HCV prevalence (Pearson Correlation = 0.218, p < 0.001).
Nigeriahépatite Cpublished 2025Journal of health, population, and nutritionPubMeddocument of 5 observations
90 %The hepatitis C virus cure (SVR12) rate was greater than 90%, including at lower-tier facilities.
Nigeriahépatite Cpublished 2020BMJ global healthPubMeddocument of 6 observations
4.5 %Hepatitis C infection was observed in 4.5% of the children.
Nigeriadrépanocytose · hépatite Cpublished 2021West African journal of medicinePubMeddocument of 10 observations
2,209,209 patientsAs of December 2019, 2,209,209 patients were screened for hepatitis C virus.
Nigeriahépatite Cobserved December 2019published 2020BMJ global healthPubMeddocument of 6 observations
4.9 %Among 265 livestock handlers in Ibadan, Nigeria, 13 (4.9%) tested positive for HCV infection.
Nigeriahépatite Cobserved October 2016 to April 2017published 2024African health sciencesPubMeddocument of 5 observations
15.7 %The most identified risk factor for hepatitis C virus infection among pregnant women in Nigeria was multiple sexual partners, reported by 15.7% of participants.
Nigeriahépatite Cpublished 2021Women's health (London, England)PubMeddocument of 7 observations
1 casesOne (1.1%) participant was positive for anti-HCV.
Nigeriahépatite Cpublished 2020Journal of immunoassay & immunochemistryPubMeddocument of 8 observations
HCV co-infection had no effect on AIDS status at baseline among treatment-naïve adult HIV-infected patients.
Nigeriahépatite C · VIH/sidapublished 2021Annals of African medicinePubMeddocument of 3 observations
Every row leads to its source document. The figure shown counts the VALIDATED observations it carries, never the extracted ones: the two differ on most documents. The exact source excerpt is not published, due to copyright constraints.